Bangladesh — All Categories

← back to leaderboard

Bangladesh received 113 FDA import refusals across all food categories between 2023-Q4 and 2026-Q3. Volume peaked at 19 in 2026-Q2, with the trend rising sharply year-on-year. The most-cited issues are salmonella, unsafe add, and nutrit lbl. No trade baseline is published for this commodity from Bangladesh, so no per-$1B rate is shown here.

Of these, 99 were hazard refusals and 14 were paperwork refusals.

Exporting from Bangladesh? Get an email when shipments from Bangladesh are refused at the US border — before your buyers ask.

Quarterly rejections, last 12 quarters

3 2023-Q4 2023-Q4: 3 14 2024-Q1 2024-Q1: 14 11 2024-Q2 2024-Q2: 11 9 2024-Q3 2024-Q3: 9 4 2024-Q4 2024-Q4: 4 7 2025-Q1 2025-Q1: 7 5 2025-Q2 2025-Q2: 5 8 2025-Q3 2025-Q3: 8 10 2025-Q4 2025-Q4: 10 17 2026-Q1 2026-Q1: 17 19 2026-Q2 2026-Q2: 19 6 2026-Q3 2026-Q3: 6

By category, last 156 weeks

Category Rejections Per $1B US imports Most-cited hazard
Fishery/Seafood Products 23 salmonella
Snack Food Items (Flour, Meal, or Vegetable Base) 8 salmonella
Vegetable Oils (Includes Olive Oil) 4 unsafe add

Recent rejections

Recent weeks

WeekBorder rejections
2026-W380
2026-W370
2026-W360
2026-W350
2026-W340
2026-W331
2026-W321
2026-W310

→ See all FDA import refusals for 2026-W38